Last checked at 5 Jan 2009 14:50
ValiRx plc
(the "Company")
Issue of equity
The Company announces that it has issued a total of 378,606 new ordinary shares of 6p each in the Company ("Ordinary Shares") to certain of its creditors who have agreed for the Company to satisfy, in aggregate, £23,618.15 of their outstanding fees by the issue of new Ordinary Shares. The Ordinary Shares were issued for the following amounts:
| Number of Ordinary Shares | Price per Ordinary Share | Total fees converted | |
| 21,505 | 7.75p | £1,666.64 | |
| 23,810 | 7.00p | £1,666.70 | |
| 22,988 | 7.25p | £1,666.63 | |
| 310,303 | 6.00p | £18,618.18 | |
| Total | 378,606 | £23,618.15 | |
Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 9 January 2009.
Following the issue of the new Ordinary Shares, the Company has 58,378,365 Ordinary Shares in issue.
For further information please contact:
| ValiRx plc Dr. Satu Vainikka | Tel: +44 (0) 20 3008 4416 |
| WH Ireland Limited | Tel: +44 (0) 161 832 2174 |
| David Youngman / Adrian Kirk | |
| College Hill | Tel: +44 (0) 20 7457 2020 |
| Adrian Duffield / Justine Lamond | valirx@collegehill.com |